Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
On-demand vs Continuous Nasal Spray for Moderate-to-severe Persistent Allergic Rhinitis
NCT05080322Phase 4Completed
- Sponsor
- Zheng Liu ENT
- Start
- Sep 2021
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate nasal spray, azelastine in allergic rhinitis (AR), sponsored by Zheng Liu ENT. Started Sep 2021; status: completed.
02
Drugs
fluticasone propionate nasal sprayazelastine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT05080322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05080322.